Macro Risk Advisors (MRA), a leading provider of global market risk analysis and derivatives trade execution for institutional investors, today announced that Adam Knoth has been promoted to Head of Equity Derivative Sales and Trading. This new leadership role enhances the firm's ability to deliver on its core mission of providing superior trade construction, execution […]
Innovative Approach Drives Profitability of Cannabis Operations for Public Shareholders Through Social Equity License Owners Health Advance Inc (OTC: HADV) www.HealthAdvanceGroup.com and strategic partner SoEquity Corporation www.SoEquityCorporation.com have approved their first social equity cannabis license owner, InLabs2 LLC of Springfield, Illinois, to participate in a unique new opportunity accelerator program. The approach taken by the
(TSX-V:CAN), DIEPPE, New Brunswick, Jan. 29, 2025 (GLOBE NEWSWIRE) — Canadian Gold Resources Ltd. (“Canadian Gold” or the “Company”) (TSX.V: CAN), a Canadian exploration company focused on developing high-grade gold projects in the Gaspe Gold Belt of Quebec, is excited to announce the preliminary interpretation of airborne magnetic survey data for its Robidoux property in
IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that the Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel. This treatment is indicated for patients with relapsed and/or refractory multiple myeloma (R/R MM)
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX) concerning possible violations of federal securities laws. On December 19, 2024, the company reported disappointing results from its RewinD-LB Phase 2b clinical trial for the pain
(NASDAQ:HNVR), Fourth Quarter Performance Highlights Net Income: Net income for the quarter ended December 31, 2024 totaled $3.9 million or $0.52 per diluted share (including Series A preferred shares). Record Non-interest Income: The Company reported record non-interest income of $4.2 million for the quarter ended December 31, 2024, an increase of $0.2 million or 5.89%
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Genuine Parts Company ("Genuine Parts Company") (NYSE:GPC) concerning possible violations of federal securities laws. On October 22, 2024, Genuine reported 3Q 2024 earnings that fell well below expectations and then lowered its
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Constellation Brands, Inc. ("Constellation Brands, Inc.") (NYSE:STZ) concerning possible violations of federal securities laws. On January 10, 2025, Constellation issued a press release announcing the company’s third quarter fiscal year 2025 results,
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Grocery Outlet Holding Corp. ("Grocery Outlet Holding Corp.") (NASDAQ:GO) concerning possible violations of federal securities laws. On May 7, 2024, Grocery Outlet reported 1Q 2024 earnings that fell well below expectations and
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Universal Display Corporation ("Universal Display Corporation") (NASDAQ:OLED) concerning possible violations of federal securities laws. On August 1, 2024, Universal reported solid 2Q 2024 results and raised the bottom-end of its full year